DANNINGER MEDICAL TECHNOLOGY, INC. AND SUBSIDIARY
EXHIBIT 11
COMPUTATION OF NET INCOME PER SHARE
For the three month and nine month periods ending September 30, 1995 and 1994
- --------------------------------------------------------------------------------
Three Months Ended Nine Months Ended
September 30, September 30,
--------------------- ---------------------
1995 1994 1995 1994
- --------------------------------------------------------------------------------
Weighted average number of
common shares outstanding.... 4,687,739 4,464,379 4,621,986 4,445,546
Shares issuable pursuant to
stock option plans and stock
warrants, less shares assumed
repurchased at the average
market prices................ 0 155,265 0 0
--------- --------- --------- ---------
Weighted average shares
outstanding, including common
stock equivalents............ 4,687,739 4,619,644 4,621,986 4,445,546
--------- --------- --------- ---------
--------- --------- --------- ---------
Net income.................... $(766,000) $ 72,757 $(609,000) $( 87,476)
--------- --------- --------- ---------
--------- --------- --------- ---------
Net income per share:......... $ (.16) $ .02 $ (.13) $ (.02)
--------- --------- --------- ---------
--------- --------- --------- ---------
- --------------------------------------------------------------------------------
Note: The application of the higher of quarter-end or year end market prices
in calculating fully-diluted earnings per share does not result in a
change to the calculation of primary earnings per share.